Skip to main content

Avricore Health Inc(AVCR-X)
TSX Venture

Today's Change
Delayed Last Update
Day Low0.065
Day High0.070
Open:0.070
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change

Top Stories: Avricore Health Inc

Select a category then submit the form to load news
HealthTab™ to Expand Across North East London
HealthTab™ to Power NHS Pilot
Avricore Health’s HealthTab™ Platform Expands to North Central London in Groundbreaking NHS Pharmacy-Led Cardiovascular Project
Avricore Grants Options
Avricore Appoints Rodger Seccombe as CEO
AVRICORE HEALTH CORPORATE UPDATE: Q1 Results and Ongoing Progress Report
AVRICORE HEALTH CORPORATE UPDATE: 2024 record year, UK expansion on track
HealthTab™ and Patients Know Best® Bring Pharmacy-Based Blood Test Results to Millions in UK
Avricore Health Corporate Update: Effective Plan, Resources Result in Success
Avricore Health Refocuses Strategy to Unlock Growth Potential
Avricore Health Recognized in Deloitte’s 2024 Technology Fast 50™ Companies to Watch
Avricore Grants Options
Avricore Health Corporate Update: Mid-Year Results Show Strong Growth, Profitability

Profile

Avricore Health Inc is a Canada-based company. The company is involved in the business of health data and point-of-care technologies. The Company has only one segment, being the HealthTab - Point of Care Business in Canada. The Company's revenues are generated from operating leases of the POCT system and the sale of testing panels.